Viveve Medical, Inc. (VIVE) financial statements (2021 and earlier)

Company profile

Business Address 345 INVERNESS DRIVE SOUTH
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7133021871
Cash and cash equivalents7133021871
Receivables1266210
Inventory, net of allowances, customer advances and progress billings3542320
Inventory3542320
Other undisclosed current assets2233121
Total current assets:1322423214112
Noncurrent Assets
Property, plant and equipment3331000
Long-term investments and receivables1123   
Long-term investments1123   
Regulated entity, other noncurrent assets      1
Other noncurrent assets0100000
Other undisclosed noncurrent assets      (1)
Total noncurrent assets:4554100
TOTAL ASSETS:1727473615112
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities36119531
Accounts payable1245310
Accrued liabilities2575210
Employee-related liabilities      0
Debt1   253
Other undisclosed current liabilities      (0)
Total current liabilities:46119783
Noncurrent Liabilities
Long-term debt and lease obligation5431298  
Long-term debt, excluding current maturities5431298  
Liabilities, other than long-term debt00100  
Other liabilities00100  
Total noncurrent liabilities:5431298  
Total liabilities:101042391583
Stockholders' equity
Stockholders' equity attributable to parent, including:7175(3)(0)4(1)
Common stock 000   
Additional paid in capital22721416010368  
Accumulated deficit(220)(198)(155)(106)(69)(49)(36)
Other undisclosed stockholders' equity attributable to parent    05235
Total stockholders' equity:7175(3)(0)4(1)
TOTAL LIABILITIES AND EQUITY:1727473615112

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues571915710
Revenue, net15710
Cost of revenue
(Cost of Goods and Services Sold)
(5)(6)(11)(8)(5)(1)(0)
Gross profit:0177300
Operating expenses(19)(32)(52)(41)(21)(12)(6)
Operating loss:(18)(31)(45)(34)(19)(12)(6)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)0(0)(0)(0)0
Interest and debt expense(1)(11)(4)(3)(1)(0)(1)
Other undisclosed loss from continuing operations before equity method investments, income taxes(2)      
Loss from continuing operations before equity method investments, income taxes:(22)(42)(49)(37)(20)(12)(6)
Loss from equity method investments(0)(1)     
Net loss:(22)(43)(49)(37)(20)(12)(6)
Net loss attributable to noncontrolling interest  (1)    
Net loss attributable to parent:(22)(43)(50)(37)(20)(12)(6)
Preferred stock dividends and other adjustments(4)(0)    0
Net loss available to common stockholders, diluted:(26)(43)(50)(37)(20)(12)(6)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(22)(43)(49)(37)(20)(12)(6)
Comprehensive loss:(22)(43)(49)(37)(20)(12)(6)
Comprehensive loss, net of tax, attributable to noncontrolling interest  (1)    
Comprehensive loss, net of tax, attributable to parent:(22)(43)(50)(37)(20)(12)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: